Cite
HARVARD Citation
Decker, T. et al. (n.d.). 295PExploratory biomarker analysis in patients treated with vinorelbine plus everolimus or vinorelbine monotherapy as second-line treatment for HER2-negative advanced breast cancer: Final results from the randomized phase II trial VicTORia. Annals of oncology. p. . [Online].